AURINIA PHARMACEUTICALS INC (AUPH) Stock News

NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD

8.63 -0.44 (-4.85%)

After market: 8.84 +0.21 (+2.43%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AUPH Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Chartmill

News Image

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) – A Strong Candidate for Growth Investors

20 days ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

21 days ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

2 months ago - By: Zacks Investment Research

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

2 months ago - By: Benzinga - Mentions: SPY ADSK INTU AAP ...

US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert

2 months ago - By: Aurinia Pharmaceuticals Inc.

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

2 months ago - By: Zacks Investment Research - Mentions: NRG HBM FOX

Company News for May 13, 2025

2 months ago - By: Zacks Investment Research - Mentions: DERM

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates

2 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

2 months ago - By: Benzinga

Uncovering Potential: Aurinia Pharmaceuticals's Earnings Preview

3 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

3 months ago - By: Aurinia Pharmaceuticals Inc.

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

3 months ago - By: Aurinia Pharmaceuticals Inc.

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

3 months ago - By: Yahoo Finance - Mentions: PEP HRTG MRX VRTX ...

Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs

3 months ago - By: Zacks Investment Research - Mentions: ESPR HRTX PSTV PYXS

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms

5 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

5 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

8 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

8 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

8 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia to Participate in Jefferies London Healthcare Conference

9 months ago - By: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth